Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin

British Journal of Clinical Pharmacology

Volumn 64, Issue 4, 2007, Pages 517-526

  Forrest, Caroline M ^a   Mackay, Gillian M ^a   Stoy, Nicholas ^b   Stone, Trevor W ^a,c   Darlington, L Gail ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b EPSOM GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Arthritis; Cytokines; Kynurenine; Melatonin; Neopterin; Tryptophan

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; KYNURENINE; LIPID PEROXIDASE; MELATONIN; NEOPTERIN; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; METABOLISM; METABOLITE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; CYTOKINES; FEMALE; HUMANS; KYNURENINE; MALE; MELATONIN; MIDDLE AGED; TREATMENT OUTCOME;

EID: 34548641697     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02911.x     Document Type: Article

References (58)

1. Ozturk HS, Cimen MYB, Cimen OB, Kacmaz M, Durak I. Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 1999 19 : 35 7.
2. Akyol O, Isci N, Temel I, Ozgocmen S, Uz E, Murat M, Buyukberber S. The relationships between plasma and erythrocyte antioxidant enzymes and lipid peroxidation in patients with rheumatoid arthritis. Joint Bone Spine 2001 68 : 311 7.
3. Jaswal S, Mehta HC, Sood AK, Kaur J. Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 2003 338 : 123 9.
4. Kamanli A, Naziroglu M, Aydilek N, Hacievliyagil C. Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Function 2003 22 : 53 7.
5. Sarban S, Kocyigit A, Yazar M, Isikan UE. Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 2005 38 : 981 6.
6. Taysi S, Polat F, Gul M, Sari RA, Bakan E. Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 2002 21 : 200 4.
7. Helmy M, Shohayeb M, Helmy MH, El-Bassiouni EA. Antioxidants as adjuvant therapy in rheumatoid disease: a preliminary study. Arzn -Forsch /Drug Res 2001 51 : 293 8.
8. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuna-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995 18 : 1 11.
9. Reiter RJ, Calvo JR, Karbownik M, Qi WB, Tan DX. Melatonin and its relation to the immune system and inflammation. Ann NY Acad Sci 2000 917 : 376 86.
10. Tan DX, Manchester LC, Reiter RJ, Plummer RF, Limson J, Weintraub ST, Qi WB. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin transformation. Free Rad Biol Med 2000 29 : 1177 85.
11. Matuszak Z, Reszka KJ, Chignell CF. Reaction of melatonin and related indoles with hydroxyl radicals. EPR and spin-trapping investigations. Free Rad Biol Med 1997 23 : 367 72.
12. Martinez-Cruz F, Pozo D, Osuna C, Espinar A, Marchante C, Guerrero JM. Oxidative stress induced by phenylketonuria in the rat. Prevention by melatonin, vitamin E, and vitamin C. J Neurosci Res 2002 69 : 550 8.
13. Baydas G, Canatan H, Turkoglu A. Comparative analysis of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes mellitus. J Pineal Res 2002 32 : 225 30.
14. Baydas G, Nedzvetsky VS, Nerush PA, Kirichenko SV, Demchenko HM, Reiter RJ. A novel role for melatonin: regulation of the expression of cell adhesion molecules in the rat hippocampus and cortex. Neurosci Lett 2002 326 : 109 12.
15. Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Physiological concentrations of melatonin inhibit nitric-oxide synthase in rat cerebellum. Life Sci 1994 55 : PL455 PL460.
16. Gilad E, Wong HR, Zingarelli B, Virag L, O'Connor M, Salzman AL, Szabo C. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation. FASEB J 1998 12 : 685 93.
17. Acuna-Castroviejo D, Escames G, Leon J, Carazo A, Khaldy H. Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol 2002 527 : 549 57.
18. Lissoni P, Pittalis S, Rovelli F, Roselli MG, Ardizzoia A. Modulation of cytokine production from TH2-lymphocytes and monocytes by the pineal neurohormone melatonin. Oncol Reports 1996 3 : 541 3.
19. Bitzer-Quintero OK, Ortiz GG, Ruiz-Rizo L, Torres-Mendoza BM, Vazquez-Valls E, Rodriguez-Perez M. Effects of melatonin on plasma levels of TNF-alpha, IL-1 and IL-6 in mice after lipopolysaccharide administration. Biol Rhythm Res 2005 36 : 159 68.
20. Lissoni P, Barni S, Tancini G, Mainini E, Piglia F, Maestroni GJM, Lewinski A. Immunoendocrine therapy with low-dose subcutaneous interleukin-2 plus melatonin of locally advanced or metastatic endocrine tumors. Oncology 1995 52 : 163 6.
21. Arendt J. Safety of melatonin in long-term use. J Biol Rhythms 1997 12 : 673 81.
22. Forrest CM, Kennedy A, Stone TW, Stoy N, Darlington LG. Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. Adv Exp Med Biol 2003 527 : 287 95.
23. Forrest CM, Mackay GM, Stoy N, Egerton M, Christofides J, Stone TW, Darlington LG. Tryptophan loading induces oxidative stress. Free Rad Res 2004 38 : 1167 71.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fried JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 31 : 315 24.
25. ICSH. ICSH Recommendations for measurement of erythrocyte sedimentation rate. Clin Pathol 1933 46 : 198 200.
26. Westergren A. Studies of the suspension stability of the blood in pulmonary tuberculosis. Med Scand 1921 54 : 247 50.
27. Fraser S, Cowen P, Franklin M, Franey C, Arendt J. Direct radioimmunoassay for melatonin in plasma. Clin Chem 1983 29 : 396 7.
28. Stoy N, Mackay GM, Forrest CM, Christofides J, Egerton M, Stone TW, Darlington LG. Tryptophan metabolism and oxidative stress in patients with Huntington's disease. J Neurochem 2005 93 : 611 23.
29. Mackay GM, Forrest CM, Stoy N, Christofides J, Egerton M, Stone TW, Darlington LG. Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol 2006 13 : 30 42.
30. Herve C, Beyne P, Jamault H, Delacoux E. Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. J Chromatog B-Biomed App 1996 675 : 157 61.
31. Shibata K. Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by HPLC. J Chromatogr-Biomed 1988 430 : 376 80.
32. Schroecksnadel K, Kaser S, Ledochowski M, Neurauter G, Mur E, Herold M, Fuchs D. Increased degradation of tryptophan in blood of patients with rheumatoid arthritis. J Rheumatol 2003 30 : 1935 9.
33. Schroecksnadel K, Winkler C, Fuith LC, Fuchs D. Tryptophan degradation in patients with gynecological cancer correlates with immune activation. Cancer Lett 2005 223 : 323 9.
34. Christofides J, Bridel M, Egerton M, Mackay GM, Forrest CM, Stoy N, Stone TW, Darlington LG. Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with Huntington's disease or chronic brain injury. J Neurochem 2006 97 : 1078 88.
35. West SK, Oosthuizen JM. Melatonin levels are decreased in rheumatoid arthritis. J Basic Clin Physiol Pharmacol 1992 3 : 33 40.
36. Fourtillan JB, Brisson AM, Gobin P, Ingrand I, Decourt JP, Girault J. Bioavailability of melatonin in humans after day-time administration of D-7 melatonin. Biopharmaceutics Drug Dispos 2000 21 : 15 22.
37. Attenburrow MEJ, Dowling BA, Sharpley AL, Cowen PJ. Case-control study of evening melatonin concentration in primary insomnia. BMJ 1996 312 : 1263 4.
38. Crasson M, Beckers V, Pequeux C, Claustrat B, Legros JJ. Daytime 50 Hz magnetic field exposure and plasma melatonin and urinary 6-sulfatoxymelatonin concentration profiles in humans. J Pineal Res 2001 31 : 234 41.
39. Hansson I, Holmdahl R, Mattsson R. The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J Neuroimmunol 1992 39 : 23 30.
40. Hansson I, Holmdahl R, Mattsson R. Pinealectomy ameliorates collagen-II-induced arthritis in mice. Clin Exp Immunol 1993 92 : 432 6.
41. Distefano A, Paulesu L. Inhibitory effect of melatonin on production of ifn-gamma or TNF-α in peripheral-blood mononuclear-cells of some blood-donors. J Pineal Res 1994 17 : 164 9.
42. Baykal A, Iskit AB, Hamaloglu E, Guc MO, Hascelik G, Sayek I. Melatonin modulates mesenteric blood flow and TNF alpha concentrations after lipopolysaccharide challenge. Eur J Surg 2000 166 : 722 7.
43. Bonilla E, Valero N, Chacin-Bonilla L, Pons H, Larreal Y, Medina-Leendertz S, Espina LM. Melatonin increases interleukin-1 beta and decreases tumor necrosis factor alpha in the brain of mice infected with the Venezuelan equine encephalomyelitis virus. Neurochem Res 2003 28 : 681 6.
44. Silva SO, Rodrigues MR, Ximenes VF, Bueno-da-Silva AEB, Amarante-Mendes GP, Campa A. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release. J Neuroimmunol 2004 156 : 146 52.
45. Shafer LL, McNulty JA, Young MRI. Assessment of melatonin's ability to regulate cytokine production by macrophage and microglia cell types. J Neuroimmunol 2001 120 : 84 93.
46. Williams JG, Bernstein S, Prager M. Effect of melatonin on activated macrophage TNF, IL-6, and reactive oxygen intermediates. Shock 1998 9 : 406 11.
47. Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M. Melatonin in rheumatoid arthritis: synovial macrophages show melatonin receptors. Ann NY Acad Sci 2002 966 : 271 5.
48. Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M. Melatonin in rheumatoid arthritis: a disease-promoting and modulating hormone? Clin Exp Rheumatol 2002 20 : 872 3.
49. Cutolo M, Villaggio B, Candido F, Valenti S, Giustu M, Felli L, Sulli A, Accardo S. Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cells. Ann NY Acad Sci 1999 876 : 246 54.
50. Sulli A, Maestroni GJ, Villaggio B, Hertens E, Craviotto C, Pizzorni C, Briata M, Seriolo B, Cutolo M. Melatonin serum levels in rheumatoid arthritis. Ann NY Acad Sci 2002 966 : 276 8.
51. Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S, Montagna P, Fazzuoli L, Veldi T, Peets T, Hertens E, Sulli A. Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 2005 64 : 212 6.
52. Cutolo M, Maestroni GJ. The melatonin-cytokine connection in rheumatoid arthritis. Ann Rheum Dis 2005 64 : 1109 11.
53. Sakano K, Oikawa S, Hiraku Y, Kawanishi S. Oxidative DNA damage induced by a melatonin metabolite, 6-hydroxymelatonin, via a unique non-o-quinone type of redox cycle. Biochem Pharmacol 2004 68 : 1869 78.
54. Gimeno MF, Landa A, Sterin-Speziale N, Cardinale DP, Gimeno AL. Melatonin blocks in vitro generation of prostaglandin by the uterus and hypothalamus. Eur J Pharmacol 1980 62 : 309 17.
55. Kelly RW, Amato F, Seamark RF. N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. Biochem Biophys Res Commun 1984 121 : 372 9.
56. Pawlikowski M, Juszczak M, Karasek E, Muszynska B, Karasek M. Melatonin inhibits prostaglandin E release from the medial basal hypothalamus of pinealectomised rats. J Pineal Res 1984 1 : 317 21.
57. Franchi AM, Gimeno MF, Cardinali DP, Vacas MI. Melatonin, 5-methoxytryptamine and some of their analogs as cyclo-oxygenase inhibitors in rat medial basal hypothalamus. Brain Res 1987 405 : 384 8.
58. Martin XD. New insights into the autonomous regulation of intraocular pressure. Curr Opin Ophthalmol 1994 5 : 15 9.